Cargando…

5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Detalles Bibliográficos
Autores principales: Bartolucci, P., Ataga, K.I., Callaghan, M., De Franceschi, L., Minniti, C., Alexandrou, A., Imbs, D.-.C., Fox, R.P., Patel, H., Sostelly, A., Schimmel, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112618/
http://dx.doi.org/10.1097/01.HS9.0000928292.81037.b2
_version_ 1785027660927205376
author Bartolucci, P.
Ataga, K.I.
Callaghan, M.
De Franceschi, L.
Minniti, C.
Alexandrou, A.
Imbs, D.-.C.
Fox, R.P.
Patel, H.
Sostelly, A.
Schimmel, J.
author_facet Bartolucci, P.
Ataga, K.I.
Callaghan, M.
De Franceschi, L.
Minniti, C.
Alexandrou, A.
Imbs, D.-.C.
Fox, R.P.
Patel, H.
Sostelly, A.
Schimmel, J.
author_sort Bartolucci, P.
collection PubMed
description
format Online
Article
Text
id pubmed-10112618
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101126182023-04-19 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) Bartolucci, P. Ataga, K.I. Callaghan, M. De Franceschi, L. Minniti, C. Alexandrou, A. Imbs, D.-.C. Fox, R.P. Patel, H. Sostelly, A. Schimmel, J. Hemasphere Poster Presentations Lippincott Williams & Wilkins 2023-04-10 /pmc/articles/PMC10112618/ http://dx.doi.org/10.1097/01.HS9.0000928292.81037.b2 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster Presentations
Bartolucci, P.
Ataga, K.I.
Callaghan, M.
De Franceschi, L.
Minniti, C.
Alexandrou, A.
Imbs, D.-.C.
Fox, R.P.
Patel, H.
Sostelly, A.
Schimmel, J.
5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_fullStr 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full_unstemmed 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_short 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_sort 5610823 trial in progress: the randomized, double-blind, placebo-controlled phase 1b crosswalk-a trial evaluating the safety of crovalimab for the management of acute uncomplicated vaso-occlusive episodes (voes) in patients (pts) with sickle cell disease (scd)
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112618/
http://dx.doi.org/10.1097/01.HS9.0000928292.81037.b2
work_keys_str_mv AT bartoluccip 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT atagaki 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT callaghanm 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT defranceschil 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT minnitic 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT alexandroua 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT imbsdc 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT foxrp 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT patelh 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT sostellya 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT schimmelj 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd